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Background: Older patients with combination of aortic coarctation and large patent ductus
arteriosus can be managed with transcatheter interventions. The strategies depend on
anatomy of coarctation and size of ductus arteriosus.
Methods: We present three different patients with this combination. The anatomic factors
like isthmic hypoplasia, dilatation of post coarctation descending aorta and size of ductus
arteriosus were noted.
Results: Patients with isthmic hypoplasia needed stent angioplasty of the coarctation. If
there is no dilatation of post coarctation aorta, a single covered stent excluded the ductus
arteriosus and relieved the coarctation gradients. Dilated post coarctation aorta precluded
a covered stent and warranted closure of duct with occluder device and stent angioplasty
of coarctation. When there is a good sized aortic isthmus in a discrete membranous
coarctation, device closure of the duct and balloon aortoplasty was successful.
Conclusions: In coarctation with patent ductus arteriosus associated with good sized aortic
isthmus, closure of duct with duct occluder device and balloon aortoplasty would correct
the lesions. If there is isthmic hypoplasia, device closure of the duct and stenting of the
coarctation is needed. Covered stent is a reasonable alternative only in presence of non
dilated descending aorta.
Copyright ª 2012, Cardiological Society of India. All rights reserved.1. Introduction the arch obstruction. Some transcatheter options have beenThe treatment of coarctation of aorta associatedwithmoderate
to largepatent ductusarteriosus (PDA)dependson thepatient’s
age, coarctation anatomy and size of the duct. Infants with
coarctation and PDA usually undergo surgical correction.
Transcatheter closure ofmoderate to large ducts with occluder
devices is practiced widely in recent years. However in the
presence of coarctation, the aortic retention skirt of the
occluder further compromises the aortic lumen and worsens.
m (K. Sivakumar).
2012, Cardiological Societdescribed in older patients with coarctation and PDA.1e4 We
present our different transcatheter approaches for treating
aortic coarctation with PDA depending on arch anatomy.2. Patient 1
A 13-year-old deaf mute girl with growth failure and
congestive heart failure presented with weak lower limby of India. All rights reserved.
Fig. 1 e Lateral view aortogram in first patient shows isthmic hypoplasia (dotted arrow) and severe preductal coarctation
(black arrow) and large PDA before (A) and after (B) covered stent deployment. MPA: main pulmonary artery, LPAL left
pulmonary artery, RVP: right ventricular pacing.
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systolic pressure gradient of 70 mmHg between upper and
lower limbs. The echocardiogram showed severe post
subclavian preductal coarctation and large PDA with
laminar left to right flows indicating severe pulmonary
hypertension. A multislice computed tomography
confirmed the diagnosis. On cardiac catheterization, there
was a systolic and mean gradient of 85 and 50 mmHg across
the coarctation. The pulmonary artery and descendingFig. 2 e Arch angiogram (A) of second patient showing the protr
mild isthmic hypoplasia (black arrow). LSA: left subclavian artery
good arch flow in stented segment (black arrows).aortic pressures were similar at 100/70 mmHg. The pulmo-
nary to systemic flow ratio was 1.8 and there was no right to
left shunt. The aortic diameter was 11 mm at the level of the
left subclavian artery and at post ductal descending aorta.
The coarctation segment was stented with 12 mm  41 mm
Advanta V12 covered stent (Atrium Medical, The
Netherlands) resulting in complete ductal closure and
reduction of pulmonary artery pressures to 60/30 mmHg
(Fig. 1). On a follow up of 4 months, she is normotensiveuding retention skirt of Amplatzer duct occluder (ADO) with
, D Ao: descending thoracic aorta. After stenting (B), there is
Fig. 3 e Aortogram in third patient (A) shows good sized isthmus and discrete juxtaductal coarctation (black arrow) and
small PDA. After device closure of duct and coarctation balloon dilatation, (B) there is complete relief of aortic obstruction.
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formed on GE Innova 2100 flat panel platform with Fluo-
rostore (GE Medical) which helped in reducing the
radiation dose to the patient.3. Patient 2
A 9-year-old girl weighing 23 kg had large PDA and mild
isthmic hypoplasia. The PDA was closed with 10-8 Amplatzer
duct occluder (AGA Medical, Minneapolis) with complete
occlusion of PDA and there was no aortic gradient after the
procedure. However during follow up over 7 years, there was
a progressive development of aortic arch gradients (systolic
andmean gradients of 50 and 25 mmHg respectively) partially
contributed by the protruding aortic retention skirt of the
device and mild isthmic hypoplasia. The coarctation was
stented with GenesisXD 1910 Stent (Cordis, Miami, FL) on
a 12  4 Maxi LD balloon and post dilated with 14  4 Maxi LD
balloon resulting in good unobstructed flow across the stented
segment (Fig. 2). She is followed up for 15 months with no
clinical gradients.4. Patient 3
A 10-year-old patient had discrete juxtaductal coarctation,
systemic hypertension, blood pressure difference of 50mmHg
between upper and lower limbs and radiofemoral delay. His
angiogram showed discrete membranous coarctation and
4 mm PDA. After deploying an 8-6 Amplatzer duct occluder
device in the PDA, coarctation was balloon dilated with
16  4 mm Z-med II balloon (NuMed, Cornwall). The post
procedure angiogram showed complete elimination of thegradients and wide-open aortic lumen (Fig. 3). In this patient,
there was a normal sized isthmus and so balloon aortoplasty
was carried out rather than stenting.5. Discussion
The transcatheter treatment for Coarctation of aorta associ-
ated with patent ductus arteriosus in older children and
adults have been sporadically reported in past, either in same
sitting or sequentially.5,6 A carefully placed covered stent
avoiding the left subclavian artery origin should achieve
a twin objective of relief of coarctation with occlusion of PDA.
However, in presence of marked poststenotic dilatation of
aorta, there will be a distal endoleak and inadequate ductal
closure.1,7 We resorted to stenting whenever isthmic hypo-
plasia is present, however balloon aortoplasty alone would
suffice if there is a good sized isthmus and the coarctation is
very discrete andmembranous. In our first two patients, there
was substantial isthmic narrowing that warranted stenting,
however in the last patient, balloon dilatation alone was
successful.6. Conclusion
Transcatheter treatment of CoA and PDA in older patients is
safe and effective. In presence of isthmic hypoplasia, stenting
may be necessary after device closure of PDA. In discrete
membranous coarctation with good sized isthmus, balloon
aortoplasty with device closure of PDA will be the method of
choice. Covered stent is an alternative option if there is no
significant poststenotic descending aortic dilatation.
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